NOVAVAX, INC. (NVAX) Operating margin 2016–2025
NOVAVAX, INC. (NVAX) operating margin by fiscal year — reported operating income divided by reported revenue.
40.3%FY2025 · since FY2016: -1752.8% → 40.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 40.3% | +76.8 pp |
| FY2024 | -36.5% | +21.1 pp |
| FY2023 | -57.6% | -25.1 pp |
| FY2022 | -32.5% | +114.6 pp |
| FY2021 | -147.1% | -59.5 pp |
| FY2020 | -87.6% | +558.5 pp |
| FY2019 | -646.1% | -138.9 pp |
| FY2018 | -507.2% | +43.5 pp |
| FY2017 | -550.8% | +1202.1 pp |
| FY2016 | -1752.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice